We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Bipartisan lawmakers in Congress introduced five bills last week meant to shore up the U.S. supply chain and address the rising costs of prescription drugs. Read More
Pfizer announced yesterday that it would acquire ReViral in a $525 million deal that will give the company ownership of ReViral’s experimental treatments for respiratory syncytial virus (RSV) infections. Read More
A trial in West Virginia before Judge Derek Swope got under way yesterday against Johnson & Johnson (J&J), Teva Pharmaceuticals and AbbVie for their alleged role in facilitating the state’s opioid crisis. Read More
AbbVie’s Allergan subsidiary and Teva Pharmaceuticals have agreed to pay nearly $330 million to settle claims that they played a role in the opioid abuse and overdose crisis in Florida. Read More